DiaMedica Therapeutics
DMAC
DMAC
32 hedge funds and large institutions have $14.9M invested in DiaMedica Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
0% more call options, than puts
Call options by funds: $8K | Put options by funds: $8K
Holders
32
Holding in Top 10
1
Calls
$8K
Puts
$8K
Top Buyers
| 1 | +$1.52M | |
| 2 | +$472K | |
| 3 | +$51.6K | |
| 4 |
MCA
Magnolia Capital Advisors
Jackson,
Mississippi
|
+$29.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4K |
Top Sellers
| 1 | -$490K | |
| 2 | -$66.5K | |
| 3 | -$51.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$46K |
| 5 |
First Manhattan
New York
|
-$32.3K |